Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-06-04 00:00:00 ET · period of report 2024-06-03 · accession 0001238403-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-04 | 2024-06-03+ | MYGN | SPIEGELMAN DANIEL K | Dir | S - Sale | $22.04 | -7,576 | 32.9K | -19% | -$167.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | S | D | 3,788 | $22.04 | 36,705 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-04 | S | D | 3,788 | $22.05 | 32,917 | D | — | — |